Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2017

Open Access 01-12-2017 | Research

Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease

Authors: Stina B Jonasson, Maria H Nilsson, Jan Lexell

Published in: Health and Quality of Life Outcomes | Issue 1/2017

Login to get access

Abstract

Background

Fear of falling is common in people with Parkinson’s disease (PD) and is associated with an increased risk for future falls, activity limitations and a reduced quality of life. The Falls Efficacy Scale-International (FES-I) assesses fear of falling conceptualized as concerns about falling. The original FES-I has good psychometric properties in people with PD, but whether this applies also for the short version of FES-I remains to be shown.
The aim of the present study was to evaluate the psychometric properties of the short FES-I and to compare these with the original FES-I in the same sample of people with PD. The investigated psychometric properties included known groups validity, data completeness, scaling assumptions, targeting and reliability.

Methods

A postal survey, which included the original, full-length FES-I, was distributed to 174 people with PD. Responders received a second survey after two weeks. From these data, short FES-I total scores were calculated by extracting the items that are included in the short version of the scale.

Results

Median age and PD duration of the 101 responders (43% women) were 73 and 5 years, respectively. The original as well as the short FES-I scores were able to discriminate (p < 0.001) between groups with and without fear of falling, activity avoidance, falls, near falls, and with various self-rated PD severity, respectively. Both versions of FES-I had a high level of data completeness (0.7 to 0.9% missing item responses). Scaling assumptions were acceptable for the original as well as the short FES-I. While the short FES-I had 19% floor effect, the original version was better targeted. Both versions were reliable and obtained high values for internal consistency (Cronbach’s alpha >0.8) and test-retest reliability (Intraclass Correlation Coefficient > 0.9).

Conclusions

Both the original and short FES-I revealed generally good psychometric properties in people with PD, although the original scale was better targeted. Due to the higher floor effect in the short FES-I, the present findings favors using the original, full-length FES-I in longitudinal follow-ups, intervention studies and clinical practice when addressing concerns about falling.
Literature
1.
go back to reference Lindholm B, Hagell P, Hansson O, Nilsson MH. Prediction of falls and/or near falls in people with mild Parkinson’s disease. PLoS One. 2015;10:e0117018.CrossRefPubMedPubMedCentral Lindholm B, Hagell P, Hansson O, Nilsson MH. Prediction of falls and/or near falls in people with mild Parkinson’s disease. PLoS One. 2015;10:e0117018.CrossRefPubMedPubMedCentral
2.
go back to reference Kader M, Iwarsson S, Odin P, Nilsson MH. Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease. BMC Neurol. 2016;16:84.CrossRefPubMedPubMedCentral Kader M, Iwarsson S, Odin P, Nilsson MH. Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease. BMC Neurol. 2016;16:84.CrossRefPubMedPubMedCentral
4.
go back to reference Tinetti ME, Powell L. Fear of falling and low self-efficacy: a cause of dependence in elderly persons. J Gerontol. 1993;48 Spec No:35–8.CrossRefPubMed Tinetti ME, Powell L. Fear of falling and low self-efficacy: a cause of dependence in elderly persons. J Gerontol. 1993;48 Spec No:35–8.CrossRefPubMed
5.
go back to reference Jonasson SB, Nilsson MH, Lexell J. Psychometric properties of four fear of falling rating scales in people with Parkinson’s disease. BMC Geriatr. 2014;14:66.CrossRefPubMedPubMedCentral Jonasson SB, Nilsson MH, Lexell J. Psychometric properties of four fear of falling rating scales in people with Parkinson’s disease. BMC Geriatr. 2014;14:66.CrossRefPubMedPubMedCentral
6.
go back to reference Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C. Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing. 2005;34:614–9.CrossRefPubMed Yardley L, Beyer N, Hauer K, Kempen G, Piot-Ziegler C, Todd C. Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing. 2005;34:614–9.CrossRefPubMed
7.
go back to reference Kempen GI, Yardley L, van Haastregt JC, Zijlstra GA, Beyer N, Hauer K, et al. The Short FES-I: a shortened version of the Falls Efficacy Scale-International to assess fear of falling. Age Ageing. 2008;37:45–50.CrossRefPubMed Kempen GI, Yardley L, van Haastregt JC, Zijlstra GA, Beyer N, Hauer K, et al. The Short FES-I: a shortened version of the Falls Efficacy Scale-International to assess fear of falling. Age Ageing. 2008;37:45–50.CrossRefPubMed
8.
go back to reference Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80:99–103.CrossRefPubMed Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80:99–103.CrossRefPubMed
9.
go back to reference Lamb SE, Jorstad-Stein EC, Hauer K, Becker C. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc. 2005;53:1618–22.CrossRefPubMed Lamb SE, Jorstad-Stein EC, Hauer K, Becker C. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc. 2005;53:1618–22.CrossRefPubMed
10.
go back to reference Gray P, Hildebrand K. Fall risk factors in Parkinson’s disease. J Neurosci Nurs. 2000;32:222–8.CrossRefPubMed Gray P, Hildebrand K. Fall risk factors in Parkinson’s disease. J Neurosci Nurs. 2000;32:222–8.CrossRefPubMed
11.
go back to reference Hobson JP, Edwards NI, Meara RJ. The Parkinson’s Disease Activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson’s disease. Clin Rehabil. 2001;15:241–6.CrossRefPubMed Hobson JP, Edwards NI, Meara RJ. The Parkinson’s Disease Activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson’s disease. Clin Rehabil. 2001;15:241–6.CrossRefPubMed
12.
go back to reference Nordell E, Andreasson M, Gall K, Thorngren K-G. Evaluating the Swedish version of the Falls Efficacy Scale-International (FES-I). Adv Physiother. 2009;11:81–7.CrossRef Nordell E, Andreasson M, Gall K, Thorngren K-G. Evaluating the Swedish version of the Falls Efficacy Scale-International (FES-I). Adv Physiother. 2009;11:81–7.CrossRef
13.
go back to reference Delbaere K, Close JCT, Mikolaizak AS, Sachdev PS, Brodaty H, Lord SR. The Falls Efficacy Scale International (FES-I). A comprehensive longitudinal validation study. Age Ageing. 2010;39:210–6.CrossRefPubMed Delbaere K, Close JCT, Mikolaizak AS, Sachdev PS, Brodaty H, Lord SR. The Falls Efficacy Scale International (FES-I). A comprehensive longitudinal validation study. Age Ageing. 2010;39:210–6.CrossRefPubMed
14.
go back to reference Guidance for Industry - Patient-reported outcome measures: Use in medical product development to support labeling claims. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). 2009. Available from http://www.fda.gov. Guidance for Industry - Patient-reported outcome measures: Use in medical product development to support labeling claims. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). 2009. Available from http://​www.​fda.​gov.
15.
go back to reference Hobart J, Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess. 2009;13:iii, ix-x, 1–177.CrossRefPubMed Hobart J, Cano S. Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess. 2009;13:iii, ix-x, 1–177.CrossRefPubMed
16.
go back to reference Ware JE Jr, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:945–52.CrossRefPubMed Ware JE Jr, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:945–52.CrossRefPubMed
17.
go back to reference Saris-Baglama RN, Dewey CJ, Chisholm GB, Kosinski M, Bjorner JB, Ware JE. SF health outcomes scoring software user’s guide. Lincoln: QualityMetric Inc; 2004. Saris-Baglama RN, Dewey CJ, Chisholm GB, Kosinski M, Bjorner JB, Ware JE. SF health outcomes scoring software user’s guide. Lincoln: QualityMetric Inc; 2004.
18.
go back to reference Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess. 2004;8:iii, 1–48.CrossRefPubMed Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess. 2004;8:iii, 1–48.CrossRefPubMed
19.
go back to reference McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4:293–307.CrossRefPubMed McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4:293–307.CrossRefPubMed
20.
go back to reference Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334.CrossRef Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334.CrossRef
21.
go back to reference Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: which coefficient should be used? Qual Life Res. 2004;13:571–86.CrossRefPubMed Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: which coefficient should be used? Qual Life Res. 2004;13:571–86.CrossRefPubMed
22.
go back to reference Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420–8.CrossRefPubMed Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420–8.CrossRefPubMed
23.
go back to reference Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.
24.
go back to reference Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205.CrossRef Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205.CrossRef
25.
go back to reference Streiner DL, Norman GR, Cairney J. Health measurement scales: a practical guide to their development and use. 5th ed. Oxford: Oxford University Press; 2015. Streiner DL, Norman GR, Cairney J. Health measurement scales: a practical guide to their development and use. 5th ed. Oxford: Oxford University Press; 2015.
26.
go back to reference Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.CrossRefPubMed Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.CrossRefPubMed
27.
go back to reference Norman GR, Streiner DL. Biostatistics: the bare essentials. 3rd ed. Shelton: People’s Medical Pub. House; 2008. Norman GR, Streiner DL. Biostatistics: the bare essentials. 3rd ed. Shelton: People’s Medical Pub. House; 2008.
Metadata
Title
Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease
Authors
Stina B Jonasson
Maria H Nilsson
Jan Lexell
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2017
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0689-6

Other articles of this Issue 1/2017

Health and Quality of Life Outcomes 1/2017 Go to the issue